Answers are grounded in this paper and cite their sources.
RCTs comparing GH with placebo or no treatment were included, and because final height data were rarely available in the context of RCTs, lower levels of evidence were included for final height only, using the highest level of evidence available within each condition. A total of 34 publications reporting 32 studies were included in the assessment of clinical effectiveness. Short-term growth and final height outcomes were evaluated along with some body composition and psychological outcomes. The Jadad quality scores of the trials ranged from 1/5 to 4/5.
No takes yet. Share an insight, caveat, or question.
Bryant et al. (2002) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: